
NYSE:JPM
This summary was created by AI, based on 49 opinions in the last 12 months.
JP Morgan Chase & Co (JPM) is highly regarded among analysts as one of the best banks globally, with strong leadership under CEO Jamie Dimon. Many experts note its impressive dividend growth over the past decade and robust share buybacks, which enhance shareholder value. The bank is positioned well to capitalize on a recovering capital markets environment, benefiting from rising interest rates and a steepening yield curve. While it trades at a premium due to its consistent performance, analysts suggest the stock remains a core holding for long-term investors, despite some concerns over economic slowdowns and cautious guidance from management. Overall, JPM is seen as a leader in the US banking sector with favorable prospects in a growing economic landscape.
Banks reported their Q2 today. JPM's loan-loss provisions are $100 billion lower a year ago if you strip out First Republic. That says something about the trajectory of the economy. Add to that the CEO's bullish comments about the economy and his bank's forecast. Without First Rep., they beat profits at 40%, a 67% profit rise with FR. Massive.
Banks have had a tough time. As we head toward the end of rate tightening, financials are a great place to be. IPO market will eventually take off. Financials have never been in a better position than today, due to regulation and good stewardship. Trades at 9x earnings, historical level for banks is 13x. 2x tangible book value, not inexpensive but you get a lot for what you pay. Cream of the crop. Yield is 2.68%.
(Analysts’ price target is $163.39)It fits the theme of buying good companies which are getting better. It is the best capitalized bank in the U.S. and also the most conservatively run. Has a great franchise in the capital markets business. It benefits from rising rates and increasing interest margins. Trades at 11X earnings with a 3% dividend and is a good solution for the re-inflationary market we're in. Buy 17 Hold 11 Sell 0
(Analysts’ price target is $157.12)
Owns shares of the company.
Favorite USA large cap banking company.
Regional banking crisis in the spring increased demand for products.
Not worried about economy slowdown impacting bank.
Reserves for loan losses have been set aside.
Good time to buy with recent share price weakness.